|
|
|
|
|
|
|
Wednesday
|
|
3 December, 2025 |
|
|
|
|
|
|
|
|
|
|
It's been just weeks since FDA Commissioner Marty Makary lobbied Rick Pazdur at his home to take the role of FDA's top drug official. And yet, Pazdur on Monday said he'll retire, with sources pointing to disagreements with Makary and with CBER Director Vinay Prasad's email to staff on newly unearthed Covid-19 vaccine deaths in children and other major changes he's floating (see below), among other issues. Who will replace Pazdur as the fifth CDER director of this year? It remains unknown. Staffers said the agency hasn't even announced that he'll retire internally, which didn't come as a surprise as they never received an email on George Tidmarsh's sudden departure as the last CDER chief. Pazdur was installed by Makary to establish some sense of continuity for experienced CDER staff that
haven't left yet, but some current and recently departed FDAers told us that they're concerned Pazdur's departure may spur an even wider exodus |
|
|
|
Zachary Brennan |
Senior Editor, Endpoints News
@ZacharyBrennan
|
|
|
|
 |
|
|
|
by Max Bayer, Zachary Brennan
|
Rick Pazdur, the head of the FDA's drug office, is expected to leave the agency less than a month after stepping into the role. His exit comes after he was personally lobbied by Commissioner Marty Makary to take the job, and was given assurances that he would be shielded from some of the chaotic dynamics that have affected other parts of the FDA, according
to previous reporting by Endpoints News. But he quickly clashed with Makary over a new National Priority Voucher pilot program, saying that it may be illegal. And he pushed back on attempts by Makary’s requests for label changes and to pull certain
unspecified drugs, Endpoints has reported. | |
|
|
|
|
|
|
by Zachary Brennan
|
A top FDA official's claim that Covid vaccines caused at least 10 deaths in children has yet to be backed up by the data that typically accompany major safety announcements, including details of the alleged deaths, which vaccines were used, and case reports that could help clinicians and researchers make their own assessments. The claim, made in a lengthy email to staff on
Friday by CBER Director Vinay Prasad, describes the alleged deaths as "a profound revelation" about the safety of the shots. It also calls for significant changes to the regulation of childhood vaccine approvals, and comes just days before HHS Secretary Robert F. Kennedy Jr.'s handpicked group of CDC advisors will discuss the childhood vaccine schedule — and potentially recommend changes to the practice of giving the hepatitis B vaccine soon after birth. | |
|
|
|
|
|
|
by Zachary Brennan
|
Details from an investigation by CBER Director Vinay Prasad into 10 alleged child deaths related to Covid-19 vaccines won't be coming soon, an FDA spokesperson told Endpoints News on Wednesday. FDA spokesperson Caleb Michaud said the agency was not releasing any more details in the "near term," since "there are additional adverse event cases being
investigated." Michaud did not say what those adverse events were, or if they were deaths. Late last week, Prasad sent an internal email to CBER staff claiming that 10 vaccine-related deaths were uncovered by “an initial analysis of 96 deaths between 2021 and 2024.” The email was reported by Endpoints News and other media outlets, but the agency has not made any official public statements, unlike in past instances when it has
investigated significant safety risks where it felt a need to inform the public and medical professionals. | |
|
|
|
|
|
|
by Nicole DeFeudis
|
The government on Tuesday announced final prices for the second round of drugs negotiated by Medicare under the Inflation Reduction Act, including for Novo Nordisk’s blockbuster semaglutide products Ozempic and Wegovy. The negotiated prices are up to 85% lower than the list prices for the drugs. The announcement gives the first substantive look at how IRA negotiations transpired under the Trump administration, which has pledged to use multiple approaches to lower drug prices. CMS said it accepted drugmakers’ revised counteroffers for seven of the drugs. The government said that when the prices take effect in 2027, patients
enrolled in Medicare prescription drug coverage will save an estimated $685 million in out-of-pocket costs. If the negotiated prices had taken effect in 2024, CMS estimates that they would have saved Medicare $12 billion in net prescription drug costs. That figure doesn’t account for spending on the Coverage Gap Discount Program, which ended in 2025. When taking that program into account, estimated savings would have been about $8.5 billion. | |
|
|
|
 |
|
ACIP chair Kirk Milhoan (Brynn Anderson/AP Images) |
|
|
|
by Max Bayer
|
The new leader of the CDC's flagship vaccine advisory group recently claimed that Covid-19 vaccines were responsible for a rise in cancer cases, and that the vast majority of women who get the vaccine in their first trimester have miscarriages. The comments by Kirk Milhoan, who serves as chairman of the CDC's Advisory Committee on Immunization
Practices, were made at a Texas church and posted on YouTube in October. Milhoan also compared pandemic-era vaccination record cards to Jews who were forced to wear specific armbands during the Holocaust. "And what they said is, if you didn't get the vaccine, then you were dirty, right? So that brings up all the issues of what happened when the Jews had to wear the yellow Star of David, right? They were the dirty ones," he said in the video. | |
|
|
|
|
|